EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DNA-Encoded Chemical Library-Based Identification of Novel Inhibitors Targeting the Essential LpxH Enzyme in Gram-Negative Bacteria

Christodoulos Mitrogiannis, Johan Wannberg, Edouard Zamaratski, Douglas L. Huseby, Sha Cao, Otto Lindahl, Stefan Lindström, Eldar Abdurakhmanov, Melania Minoia, John M. Pruneau, Xia Tian, Corey Bienstock und 13 weitere

ACS Infectious Diseases · 21.11.2026

DOI: 10.1021/acsinfecdis.6c01082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 21.11.2026. Verfasst von Christodoulos Mitrogiannis und 24 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsr?det, Magnus Bergvalls Stiftelse, Uppsala Antibiotic Center.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

LpxH is a key enzyme in the lipid A biosynthesis pathway and a promising target for the development of new antibiotics against Gram-negative pathogens. We report the discovery and optimization of two structurally distinct LpxH inhibitor series discovered through DNA-encoded chemical library (DEL) screening. Our DEL affinity selections identified a known sulfonyl piperazine class (Series 1), and a novel biphenyl-pyrimidine scaffold (Series 2) that represented a new chemical starting point for LpxH inhibitor development. To overcome liabilities, like poor solubility and low potency, a structure-based drug design approach was used for downstream hit expansion. Optimization of Series 1 yielded compound 14, which achieved wild-type activity against E. coli. Optimization of Series 2 led to compounds 21 and 24, displaying a MIC of 16 μg/mL against efflux-defective and hyperpermeable E. coli and a MIC of 8 μg/mL against efflux-defective E. coli respectively. Target engagement was confirmed via bacterial genetic sensitization experiments, demonstrating a LpxH-mediated mechanism of action.

Förderung

  • Vetenskapsr?det
  • Magnus Bergvalls Stiftelse
  • Uppsala Antibiotic Center

Zitieren

APA

Mitrogiannis, C., Wannberg, J., Zamaratski, E., Huseby, D. L., Cao, S., Lindahl, O., Lindström, S., Abdurakhmanov, E., Minoia, M., Pruneau, J. M., Tian, X., Bienstock, C., Centrella, P. A., Fair, R. J., Guié, M., Hupp, C. D., Le-Marshall, J., Zhang, Y., Roos, A. K., …, & Verho, O. (2026). DNA-Encoded Chemical Library-Based Identification of Novel Inhibitors Targeting the Essential LpxH Enzyme in Gram-Negative Bacteria. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.6c01082

Vancouver

Mitrogiannis C, Wannberg J, Zamaratski E, Huseby DL, Cao S, Lindahl O, et al. DNA-Encoded Chemical Library-Based Identification of Novel Inhibitors Targeting the Essential LpxH Enzyme in Gram-Negative Bacteria. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.6c01082

BibTeX
@article{Mitrogiannis2026,
  author = {Mitrogiannis, Christodoulos and Wannberg, Johan and Zamaratski, Edouard and Huseby, Douglas L. and Cao, Sha and Lindahl, Otto and Lindström, Stefan and Abdurakhmanov, Eldar and Minoia, Melania and Pruneau, John M. and Tian, Xia and Bienstock, Corey and Centrella, Paolo A. and Fair, Richard J. and Guié, Marie-Aude and Hupp, Christopher D. and Le-Marshall, Jennifer and Zhang, Ying and Roos, Annette K. and Sooriyaarachchi, Sanjeewani and Mowbray, Sherry and Hughes, Diarmaid and Turunen, S. Pauliina and Karlén, Anders and Verho, Oscar},
  title = {DNA-Encoded Chemical Library-Based Identification of Novel Inhibitors Targeting the Essential LpxH Enzyme in Gram-Negative Bacteria},
  journal = {ACS Infectious Diseases},
  year = {2026},
  doi = {10.1021/acsinfecdis.6c01082}
}
Kostenlos starten →